Approved PLCO Projects
Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
---|---|---|---|---|---|
Identification of genetic and lifestyle determinants of estrogen metabolism profiles | Fangcheng Yuan | Vanderbilt University Medical Center | PLCO | Apr 19, 2023 | PLCO-1199 |
Association of dietary and supplemental antioxidant intake with ovarian cancer risk | Yifu Zeng | The Second Affiliated Hospital of Fujian Medical University | PLCO | Apr 19, 2023 | PLCO-1198 |
Developing an Accurate and Interpretable Risk-Based Model for Lung Cancer Screening | Yi Luo | Moffitt Cancer Center | PLCO | Apr 19, 2023 | PLCO-1205 |
Methods study for number of controls per case to choose in GWAS | Hormuzd Katki | NCI | PLCO | Apr 13, 2023 | PLCO-1200 |
Association between BMI, Weight Change and Risk of Lung Cancer in the PLCO Cancer Screening Trial | Yixiang Zhang | The Second Affiliated Hospital of Fujian Medical University | PLCO | Apr 10, 2023 | PLCO-1194 |
Development of a Machine Learning Model for Risk Prediction of Ovarian Cancer | Yixiang Zhang | The Second Affiliated Hospital of Fujian Medical University | PLCO | Apr 10, 2023 | PLCO-1192 |
Imbalanced Learning on Cancer Datasets | Weitong Huang | Australian National University | PLCO | Mar 29, 2023 | PLCO-1189 |
The delays in ovarian cancer treatment and their effect on OS | Kaja Michalczyk | Pomeranian Medical University | PLCO | Mar 29, 2023 | PLCO-1187 |
A Research Investigation on the Association between Various Dietary Patterns and the Incidence Risk of Pancreatic Cancer | Xi Zhang | Beijing Chao-Yang Hospital, Capital Medical University | PLCO | Mar 21, 2023 | PLCO-1182 |
Ultra-processed food consumption and cancer-related mortality in patients with colorectal, lung, prostate, or breast cancer: a post hoc analysis of the PLCO cancer screening trial | Guo-Chao Zhong | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Mar 20, 2023 | PLCO-1180 |
Quantifying cancer screening overdiagnosis using synthetic excess incidence | Stuart Baker | National Cancer Institute | PLCO | Mar 20, 2023 | PLCO-1178 |
Association between adherence to the Eat-Lancet Diet and lung cancer incidence and mortality in the US population: A prospective cohort study | Linglong Peng | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Mar 16, 2023 | PLCO-1177 |
Genome-Wide Association Study of Circulating Estradiol in Postmenopausal Women | Neil Murphy | International Agency for Research on Cancer | PLCO | Mar 8, 2023 | PLCO-1170 |
Reduced rank regression derived dietary patterns and risk of colorectal cancer and mortalit | zegeye Abitew | Flinders University, Flinders Health and Medical Research Institute, College of Medicine and Public Health, Adelaide, South Australia | PLCO | Feb 27, 2023 | PLCO-1166 |
The Use of Machine Learning to predict if patients with Renal Cancer will surivive or not | Vineel Ramineni | Academies of Loudoun | PLCO | Feb 27, 2023 | PLCO-1169 |
Blood-based biomarkers for risk assessment and early detection of colorectal cancers | Samir Hanash | University of Texas MD Anderson Cancer Center | PLCO | Feb 23, 2023 | 2022-0046 |
Carcinikos - Presentiment of Cancer in Male using multi modal techniques | Ananthanagu U | PES University | PLCO | Feb 21, 2023 | PLCO-1168 |
Phenome-Wide Association Studies of the immune-related genetic variants | Feng Chen | ​Nanjing Medical University | PLCO | Feb 14, 2023 | PLCO-1165 |
Instrumental Variables Methods Reconcile Disparate Intention-to-Treat Effects Across Pragmatic Trials | Joshua Angrist | Massachusetts Institute of Technology | PLCO | Feb 8, 2023 | PLCO-1162 |
AI Model for Predicting Outcomes in Incidences of Colorectal Cancer. | Siofra Murdoch | Harvard University | PLCO | Feb 8, 2023 | PLCO-1161 |